Document Detail


Pressure-derived versus pressure wave amplitude-derived indices of cerebrovascular pressure reactivity in relation to early clinical state and 12-month outcome following aneurysmal subarachnoid hemorrhage.
MedLine Citation:
PMID:  22324419     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Object Indices of cerebrovascular pressure reactivity (CPR) represent surrogate markers of cerebral autoregulation. Given that intracranial pressure (ICP) wave amplitude-guided management, as compared with static ICP-guided management, improves outcome following aneurysmal subarachnoid hemorrhage (SAH), indices of CPR derived from pressure wave amplitudes should be further explored. This study was undertaken to investigate the value of CPR indices derived from static ICP-arterial blood pressure (ABP) values (pressure reactivity index [PRx]) versus ICP-ABP wave amplitudes (ICP-ABP wave amplitude correlation [IAAC]) in relation to the early clinical state and 12-month outcome in patients with aneurysmal SAH. Methods The authors conducted a single-center clinical trial enrolling patients with aneurysmal SAH. The CPR indices of PRx and IAAC of Week 1 after hemorrhage were related to the early clinical state (Glasgow Coma Scale [GCS] score) and 12-month outcome (modified Rankin Scale score). Results Ninety-four patients were included in the study. The IAAC, but not the PRx, increased with decreasing GCS score; that is, the higher the IAAC, the worse the clinical state. The PRx could differentiate between survivors and nonsurvivors only, whereas the IAAC clearly distinguished the groups "independent," "dependent," and "dead." In patients with an average IAAC ≥ 0.2, mortality was approximately 3-fold higher than in those with an IAAC < 0.2. Conclusions The IAAC, which is based on single ICP-ABP wave identification, relates significantly to the early clinical state and 12-month outcome following aneurysmal SAH. Impaired cerebrovascular pressure regulation during the 1st week after a bleed relates to a worse outcome. Clinical trial registration no.: NCT00248690.
Authors:
Per Kristian Eide; Angelika Sorteberg; Gunnar Bentsen; Pål Bache Marthinsen; Audun Stubhaug; Wilhelm Sorteberg
Related Documents :
8225529 - Angiotensin ii/prostaglandin i2 interactions in spontaneously hypertensive rats.
6154159 - Effects of converting enzyme inhibitor (sq 20881) on changes in blood pressure and plas...
2529779 - Atrial natriuretic peptide reverses angiotensin-induced venoconstriction in dogs.
10437739 - Safety and efficacy of angiotensin ii receptor antagonists.
18156169 - Genetically altered animal models for mas and angiotensin-(1-7).
6684189 - Inhibitory action of prostaglandin e on angiotensin ii-induced enhancement of vasoconst...
9441789 - The protective effects of prostaglandin e1 on sinusoidal endothelial cells in xenogenei...
3973829 - Guinea-pig model of halothane-associated hepatotoxicity in the absence of enzyme induct...
9709339 - A randomized, controlled trial of two-thumb vs two-finger chest compression in a swine ...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-2-10
Journal Detail:
Title:  Journal of neurosurgery     Volume:  -     ISSN:  1933-0693     ISO Abbreviation:  -     Publication Date:  2012 Feb 
Date Detail:
Created Date:  2012-2-13     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0253357     Medline TA:  J Neurosurg     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
Departments of Neurosurgery.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Improvement of neurological recovery and stimulation of neural progenitor cell proliferation by intr...
Next Document:  Neuroprotective and neurorestorative effects of thymosin ?4 treatment initiated 6 hours after trauma...